UHPLC – the technology and packing

Published: 15-Apr-2014

The science of separation is key to many aspects of drug discovery and development, and frequently involves ultra high-performance liquid chromatography. Richard Henry, Consultant, and Wayne Way, Supelco, look at its development and give advice on which packing to choose

You need to be a subscriber to read this article.
Click here to find out more.

The HPLC separation technique is widespread in pharmaceutical and chemical industries where its accuracy, precision and selectivity are important to the research, development, production and quality control of many commercial products. During the 1970s, spherical silica particles rapidly displaced first generation granular particles for analytical applications because they were much easier to prepare into stable columns. The first spherical silicas designed for HPLC appeared commercially as thin porous layers on solid silica cores, but their applications were limited due to very low surface area, phase coverage and retention factors.

Totally porous, spherical silica dominated the HPLC market from the 1980s to the 2000s with average particle size continually decreasing from 10µm to 5µm to 3µm.1,2 The trend towards smaller particles is driven by improved performance in terms of speed, sensitivity, and resolution. Smaller particles, however, require higher operating pressures, and in 2004 instruments were commercialised that could utilise columns prepared with sub-2µm particles. Figure 1 illustrates the chromatographic performance of four typical particle sizes used in HPLC. It is clear from Figure 1 that smaller particles lead to greater efficiency, resolving power and sensitivity.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like